ASLMS - American Society for Laser Medicine and Surgery
ASLMS - American Society for Laser Medicine and Surgery Professional Development Institute Annual Conference Member Services Research Grants-Awards Industry Consumer Resources

Annual Conference

 

 

 

Cutaneous Laser Surgery Session

Maryland C&D    

April 3, 2009

1:00 pm – 5:30 pm

 

 

LASER AND LIGHT THERAPY FOR THE TREATMENT OF VASCULAR LESIONS

Educational Needs

This session focuses on the use of lasers and light sources for the treatment of cutaneous vascular lesions. The topics of new treatment approaches for port wine stains and combination approach for targeting vascular lesions will be addressed in this session.  Participants will develop an understanding of the present treatment indications, therapeutic techniques, and new and innovative technologies.

Participants

This session will benefit physicians and health care personnel who treat vascular cutaneous disorders in the disciplines of dermatology, plastic surgery, otolaryngology, facial plastic surgery, and vascular surgery. It will also benefit those engineers and medical device personnel who actively work to develop devices for the treatment of cutaneous disorders.

Background Requirements

Participants should have a basic understanding of the fundamentals of skin biology, laser physics, and laser tissue interaction.

Instructional Content and/or Expected Learning Outcomes

Attendees will gain knowledge of cutting edge laser and light sources and their clinical applications in the area of cutaneous vascular lesions.

Hot Topics

  • Fractional CO2 treatment for port wine stains
  • Treatment of resistant port wine stains with a 755nm laser

 

 

1:00 pm – 1:05 pm

54

TREATMENT OF PERIORBITAL DARK CIRCLES WITH A 595nm PULSED DYE LASER

Arielle Kauvar1, New York Laser & Skin Care, New York, NY

1Equipment from Candela

 

     

1:06 pm – 1:11 pm

55

IPL AND VARIABLE LONG PULSED Nd:YAG LASER IN THE TREATMENT OF HEMANGIOMAS, VASCULAR MALFORMATIONS AND OTHER THICK VASCULAR LESIONS: A 5 YEAR EXPERIENCE

Antonio Campo-Voegeli, Maria Pilar Arboles-Bermejo, Barcelona, Spain

 

     

1:12 pm – 1:17 pm

56

CLACS GUIDED BY THE VEINVIEWER: OPTIONAL THERAPY FOR TREATING VASCULAR ABNORMALITIES (4 YEARS EXPERIENCE)

Kasuo Miyake1, Rodrigo Kikuchi, Flavio Duarte, John Davidson, John Hovorka, Clinica Miyake, São Paulo, Brazil, Solara Hospital, McAllen, TX

1Equipment and travel expenses from VeinViewer

 

     

1:18 pm – 1:23 pm

57

TREATMENT OF VASCULAR LESIONS WITH AN IPL vs PULSED DYE LASER

Michael Drosner, Jurgen Ellwanger, Kristina Schottle, Markus Stockmeier, Florian Gatty, Georg Hellbruge1, Kare Christiansen, E. Victor Ross1, Scripps Clinic, San Diego, CA, Cutaris Zentrum fur Haut, Dermatologische Klinik and Poliklinik der Technischen Universitat, Munchen, Germany, Praxis Dr. med. Markus Stockmeier, Ingolstadt, Germany, Praxis Dres. Dorzapfand Kollegen,  Augsburg, Germany, Dan-Medico, Gentofte, Denmark

1Equipment from Ellipse

●Content discusses non-FDA approved device or off-label use

 

     

1:24 pm – 1:29 pm

58

TREATMENT OF SUPERFICIAL INFANTILE HEMANGIOMAS OF THE EYELID WITH THE 595nm PULSED DYE LASER

Christopher Hunzeker, Roy Geronemus, Laser & Skin Surgery Center of New York, New York, NY

 

     

1:30 pm – 1:36 pm

 

Q&A

 

 

 

LATE-BREAKING ABSTRACT

1:37 pm – 1:42 pm

59

PRELIMINARY RESULTS OF A MULTI-CENTER CLINICAL TRIAL USING MICRO-FOCUSED ULTRASOUND FOR BROW LIFT AND IMPROVEMENT OF FACIAL SKIN LAXITY AND TEXTURE

Jeffrey Dover1, Kenneth Arndt1, Murad Alam1, Brian Zelickson1, E. Victor Ross1, Randall Miller2, SkinCare Physicians, Chestnut Hill, MA, Northwestern University, Chicago, IL, Zel Skin and Laser Specialists, Edina, MN, Scripps Clinic Carmel Valley, San Diego, CA, Ulthera, Inc., Mesa, AZ

1Equipment and research grant from Ulthera

2Travel expenses, salary, stockholder, and equity position with Ulthera

●Content discusses non-FDA approved device or off-label use

 

     

1:43 pm – 1:48 pm

60

TREATMENT OF PEDIATRIC PORT WINE STAINS USING INTENSE PULSED LIGHT WITH OPTIMIZED WAVELENGTH SPECTRUM 

Jean-Luc Levy1, Delphine Forestier, Anne Levy, Centre Laser Dermatologique, Marseille, France

1Equipment and travel expenses from Palomar

 

     

1:49 pm – 1:54 pm

61

FRACTIONAL CO2 TREATMENT OF PORT WINE STAIN BIRTHMARKS

Hilda Justiniano, Andrea Willey, Marla McClaren, Suzanne Kilmer, Laser & Skin Surgery Center of Northern California, Sacramento, CA

●Content discusses non-FDA approved device or off-label use

 

     

1:55 pm – 2:00 pm

62

A SIMPLE SOLUTION TO A COMMON PROBLEM

Elizabeth Hale, Julie Karen, Chris Hunzeker, Elliot Weiss, Leonard Bernstein, Lori Brightman, Anne Chapas, Roy Geronemus, Laser & Skin Surgery Center of New York, New York University, Langone Medical Center, New York, NY

     
2:01 pm – 2:06 pm

63

COMBINED THERAPY FOR ENHANCED MICROVASCULAR DESTRUCTION IN PORT WINE STAINS: PULSED DYE LASER PHOTOTHERMOLYSIS AND IMIQUIMOD

Anne Marie Tremaine, Arisa Ortiz, Jennifer Armstrong, Yu-Chih Huang, Laila Elkeeb, Bernard Choi, Kristen Kelly1, Beckman Laser Institute and Medical Clinic, University of California, Irvine, CA, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI

1Financial and research grants from Graceway Pharmaceuticals

●Content discusses non-FDA approved device or off-label use

 

     

2:07 pm – 2:13 pm

 

Q&A

 

     

2:14 pm – 2:19 pm

64

TREATMENT OF RESISTANT PORT WINE STAINS WITH A 755nm LASER:  A CASE SERIES OF 19 PATIENTS

Leonid Izikson, J. Stuart Nelson1, R. Rox Anderson1, Wellman Center for Photomedicine, Boston, MA, Beckman Laser Institute and Medical Clinic, University of California, Irvine, CA

1Royalties from Candela

     

2:20 pm – 2:25 pm

65

TREATMENT OF PORT WINE STAIN WITH 595nm PULSE DYE LASER: SINGLE PASS vs DOUBLE PASS WITH 6 MINUTES INTERVAL

Marieke A.D. Peters, Albert Wolkerstorfer, Martin J.C. van Gemert, J.P.Wietze van der Veen, Jan D. Bos, Johan F. Beek, Netherlands Institute for Pigment Disorders and Laser Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

     

2:26 pm – 2:31 pm

66

LATE-BREAKING ABSTRACT

PERIORAL FIBRO-FATTY RESIDUUM TREATED WITH FRACTIONAL CO2 RESURFACING

Andrea Willey, Suzanne Kilmer, Laser & Skin Surgery Center of Northern California, Sacramento, CA

●Content discusses non-FDA approved device or off-label use

     

2:32 pm – 2:37 pm

67

LATE-BREAKING ABSTRACT

ENHANCEMENT OF FRACTIONAL LASER TREATMENT USING A POINTED-COMPRESSION APPROACH

E. Victor Ross1, Gregory Altshuler2, Ilya Yaroslavsky2, Rich Cohen2, Jim Childs2, Scripps Clinic, San Diego, CA, Palomar Medical Technologies, Burlington, MA

1Equipment, consulting fees, research grant, and honoraria from Palomar

2Salary from Palomar

●Content discusses non-FDA approved device or off-label use

 

     

2:38 pm – 2:44 pm

 

Q&A

 

     

2:45 pm – 3:30 pm

 

BREAK – VISIT THE EXHIBITS AND VIEW ePOSTERS

 

     

ABLATIVE FRACTIONAL LASER TREATMENT

 Educational Needs

This session focuses on the use of fractionated CO2 lasers for the treatment of cutaneous conditions. Each of the topics of periorbital treatment, acne scars, photoaging and complications will be discussed.  Participants will develop an understanding of the present treatment indications and therapeutic techniques.

Participants

This session will benefit physicians and health care personnel who treat cutaneous disorders in the disciplines of dermatology, plastic surgery, and facial plastic surgery. It will also benefit those engineers and medical device personnel who actively work to develop devices for the treatment of cutaneous disorders.

Background Requirements

Participants should have a basic understanding of the fundamentals of skin biology, laser physics, and laser tissue interaction.

Instructional Content and/or Expected Learning Outcomes

Attendees will gain knowledge of cutting edge laser treatments and their clinical applications in the area of cutaneous conditions.

Hot Topics

  • Blepharoplasty like results with periorbital fractionated CO2 laser resurfacing
  • Hypertrophic scarring of the neck following fractional CO2

 

3:30 pm – 3:35 pm

68

TREATMENT OF MODERATE TO SEVERE ACNE SCARRING WITH FRACTIONATED CO2 LASER IN AN ASIAN POPULATION

Yi Shi Wang, Yong Kwang Tay, Colin Kwok, Regina Lim, Changi General Hospital, Singapore, Singapore

 

     

3:36 pm – 3:41 pm

69

SPLIT FACED COMPARISON OF TWO ABLATIVE FRACTIONAL CO2 LASERS FOR TREATMENT OF PHOTODAMAGED SKIN

Dendy Engelman, Mussarrat Hussain, Naana Boakye, David Goldberg, Skin and Laser Specialists of NY/NJ, New York, NY

     

3:42 pm – 3:47 pm

70

OBJECTIVE IN VIVO ASSESSMENT OF THE HEALING TIME AND THE HEALING OUTCOME BY CONFOCAL MICROSCOPY IN PATIENTS GOING TO A LASER ASSISTED MICROABLATIVE FRACTIONAL RESURFACING:  COMPARATIVE STUDY

Eva Ciscar, Antonio Pardo, Xavier Alvarez, Gabriel Buendia, Barcelona, Spain

 

     
3:48 pm – 3:53 pm

71

HYPERTROPHIC SCARRING OF THE NECK  FOLLOWING FRACTIONATED CO2 RESURFACING

Mathew M. Avram, Whitney D. Tope, Edward Szachowicz, J. Stuart Nelson, Facial Plastic Surgery, Advancements in Dermatology, Edina, MN, Beckman Laser Institute and Medical Clinic, University of California, Irvine, CA, Massachusetts General Hospital, Harvard Medical School, Boston, MA

 

     

3:54 pm – 3:59 pm

72

ERUPTIVE SQUAMOUS CELL CARCINOMA FOLLOWING FRACTIONATED CO2 LASER RESURFACING OF PHOTODAMAGED SKIN

Whitney D. Tope, Edward Szachowicz, Whitney Tope, Facial Plastic Surgery, Advancements in Dermatology, Edina, MN

 

     

4:00 pm – 4:05 pm

73

TREATMENT OF CUTANEOUS PHOTODAMAGE AND ATROPHIC SCARS WITH A

FRACTIONATED CO2 LASER: EXTENDED EXPERIENCE

Elizabeth Tanzi1, Tina Alster1, Washington Institute of Dermatologic Laser Surgery, Washington, DC

1Equipment from Lumenis and Reliant

 

4:06 pm – 4:12 pm

 

Q&A

 

     

4:13 pm – 4:18 pm

74

LONG-TERM EFFICACY OF A FRACTIONAL RESURFACING DEVICE

Arisa Ortiz, Anne Marie Tremaine, Christopher Zachary1, University of California, Irvine, CA

1Financial grant, research grant, and equipment from Reliant

●Content discusses non-FDA approved device or off-label use

 

     

4:19 pm – 4:24 pm

75

IN VIVO STUDY OF FRACTIONATED CO2 LASER HANDPIECE USED WITH STANDARD CO2 LASER FOR FRACTIONAL ABLATIVE SKIN RESURFACING

Benjamin Raab1, Aurora, IL

1Financial grant, research grant, and equipment from Alma Lasers

●Content discusses non-FDA approved device or off-label use

 

     

4:25 pm – 4:30 pm

76

FRACTIONAL CO2 LASER RESURFACING FOR SKIN REJUVENATION IN ASIANS

Nicola P.Y. Chan, Henry H.L Chan, The University of Hong Kong, Hong Kong SAR, China

 

     

4:31 pm – 4:36 pm

77

BLEPHAROPLASTY-LIKE RESULTS WITH PERIORBITAL FRACTIONAL CO2 LASER

Lori Brightman, Anne Chapas, Chris Hunzeker, Elliot Weiss, Julie Karen, Elizabeth Hale, Leonard Bernstein, Roy Geronemus1, Laser & Skin Surgery Center of New York, New York, NY

1Stockholder with Reliant

 

     
4:37 pm – 4:42 pm

78

STATE MEDICAL BOARD REGULATION OF MINIMALLY INVASIVE COSMETIC PROCEDURES: CURRENT INTERPRETATIONS AND FUTURE TRENDS FROM ONE-ON-ONE INTERVIEWS

Murad Alam, Samreen Choudhry, Simon Yoo, Northwestern University, University of Illinois, Chicago, IL

●Content discusses non-FDA approved device or off-label use

 

     

4:43 pm – 4:49 pm

 

Q&A

     

4:50 pm – 4:55 pm

79

AMINOLEVULINIC ACID PHOTODYNAMIC THERAPY DELIVERED AFTER ABLATIVE FRACTIONAL RESURFACING IN AN ANIMAL MODEL

Fernanda H. Sakamoto, Molly Wanner, William A. Farinelli, Apostolos G. Doukas, R. Rox Anderson1, Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA

1Equipment from Reliant

●Content discusses non-FDA approved device or off-label use

     

4:56 pm – 5:01 pm

80

ACCELERATING WOUND HEALING RECOVERY BY LLLT THERAPY AFTER AN ABLATIVE FRACTIONAL RESURFACING PROCEDURE

Daniel Barolet1, Ilya Yaroslavsky1, Richard Cohen1, McGill University and RoseLab Skin Optics Research Laboratory, Montreal, QB, Canada, Palomar Medical Technologies, Burlington, MA

1Discount from Palomar

●Content discusses non-FDA approved device or off-label use

     

5:02 pm – 5:07 pm

81

COMBINED ABLATIVE AND NON-ABLATIVE FRACTIONAL TREATMENT FOR FACIAL SKIN REJUVENATION

Lawrence Bass1, Matthew Del Guzzo, Sean Doherty2, Brooke Seckel3, New York University Medical Center, New York, NY, Boston Plastic Surgery Associates, Concord, MA

1Equipment and consulting fees from Palomar

2Travel expenses and salary from Palomar

3Consulting fees, discount, and travel expenses from Palomar

●Content discusses non-FDA approved device or off-label use

     

5:08 pm – 5:13 pm

82

SKIN FREEZING DURING ABLATIVE FRACTIONAL RESURFACING: IN VITRO EFFECTS ON THERMAL LESION SIZE

Dieter Manstein1, Garuna Kositratna, Wellman Center for Photomedicine, Boston, MA

1Royalties from Reliant

●Content discusses non-FDA approved device or off-label use

     

5:14 pm – 5:19 pm

83

IN VIVO HISTOPATHOLOGICAL COMPARISON OF ACUTE INJURY FOLLOWING TREATMENT WITH FIVE FRACTIONAL ABLATIVE LASER DEVICES

Jordan Farkas, Steven Bailey, James Richardson, John Hoopman, Spencer Brown, Jeffrey Kenkel, UT Southwestern, Dallas, TX

     

5:20 pm – 5:25 pm

84

LATE-BREAKING ABSTRACT

ADVANTAGES OF A GROOVE PATTERN OF MICRO-FRACTIONAL ABLATION FOR FACIAL SKIN RESURFACING

Sean Doherty1, Brooke Seckel2, E. Victor Ross3, Boston Plastic Surgery Associates, Concord, MA, Scripps Clinic, San Diego, CA1Received equipment, travel expenses, and research grant from Palomar2Received equipment, consulting fees, and travel expenses from Palomar3Received equipment, consulting fees, travel expenses, and research grant from Palomar

●Content discusses non-FDA approved device or off-label use

     

5:26 pm – 5:30 pm

 

Q&A

     
     

 
Bookmark and Share       Follow us on Facebook Follow us on LinkedinFollow us on TwitterYouTubePinterest  Google+
About Us  |  Contact Us  |  Join ASLMS  |  Early Career Opportunities  |  Job Postings  |  Site Map
©  American Society for Laser Medicine and Surgery.  All Rights Reserved.